Press Releases from DelveInsight (483 total)
Arteriovenous (AV) Fistula - Pipeline Insight, 2025: Advancing Therapies for Enh …
The treatment landscape for Arteriovenous (AV) fistula, a critical component of vascular access in hemodialysis for end-stage renal disease (ESRD) patients, is witnessing noteworthy advancements.…
Bardet-Biedl Syndrome Pipeline 2025: Emerging Therapies Transforming Multisystem …
The therapeutic landscape for Bardet-Biedl Syndrome (BBS)-a rare, genetically heterogeneous disorder affecting multiple organ systems, including the retina, kidneys, limbs, and metabolism-is undergoing significant evolution…
Osteochondrodysplasia Market Set to Witness Notable Expansion by 2034, Driven by …
Osteochondrodysplasia, a group of rare, inherited skeletal disorders characterized by abnormal development of bone and cartilage, presents significant clinical challenges due to its heterogeneity, early…
Parry-Romberg Syndrome Market Expected to Witness Moderate Growth Through 2034, …
Parry-Romberg Syndrome (PRS), also known as progressive hemifacial atrophy, is a rare neurocutaneous disorder primarily characterized by the progressive shrinkage and degeneration of tissues beneath…
Facioscapulohumeral Muscular Dystrophy Market Set for Growth Through 2034, Drive …
Facioscapulohumeral Muscular Dystrophy (FSHD), one of the most prevalent forms of muscular dystrophy, is a rare and progressive genetic disorder characterized by muscle weakness and…
Alagille Syndrome Pipeline 2025: Targeted Innovations Shaping the Future of Rare …
The therapeutic landscape for Alagille Syndrome (ALGS)-a rare, genetic disorder primarily affecting the liver and bile ducts-is evolving rapidly, driven by increased research into its…
Scars Treatment Pipeline 2025: Innovation Driving Aesthetic and Clinical Advance …
The treatment landscape for scars is undergoing a transformative shift as the demand for more effective, aesthetic, and patient-friendly solutions continues to grow. Scarring-whether caused…
Recurrent Blood Clots Market Expected to Witness Transformational Growth Through …
Recurrent Blood Clots, also called Thrombophilia, is a rare, life-threatening hematologic disorder characterized by complement-mediated hemolysis, thrombosis, and bone marrow failure. Despite being ultra-rare, PNH…
Avascular Necrosis Market Set for Steady Growth Through 2034 | DelveInsight
Avascular Necrosis (AVN), also known as osteonecrosis, is a debilitating orthopedic disorder caused by the loss of blood supply to the bone, leading to bone…
Atherosclerosis Market Expected to Expand Significantly Through 2034, Featuring …
Atherosclerosis, a chronic and progressive cardiovascular condition marked by the buildup of plaque within arterial walls, remains a leading cause of heart attacks, strokes, and…
Angioimmunoblastic T-Cell Lymphoma Market Forecast to Expand by 2034 Amid Rising …
Angioimmunoblastic T-Cell Lymphoma (AITL) is a rare and aggressive subtype of peripheral T-cell lymphoma (PTCL), characterized by systemic symptoms, immune dysregulation, and frequent genetic mutations…
Paroxysmal Hemoglobinuria Market Expected to Witness Transformational Growth Thr …
Paroxysmal Hemoglobinuria is a rare, life-threatening hematologic disorder characterized by complement-mediated hemolysis, thrombosis, and bone marrow failure. Despite being ultra-rare, PNH poses a high burden…
SGLT2 Inhibitors Market to Accelerate Through 2034 with Expanding Indications an …
Sodium-glucose co-transporter 2 (SGLT2) inhibitors have redefined the treatment paradigm for type 2 diabetes and are rapidly gaining traction across cardio-renal-metabolic diseases. Initially developed for…
Cardiorenal Syndrome Market Outlook 2034: Rising Awareness, Diagnostic Advances, …
Cardiorenal Syndrome (CRS) represents a complex pathophysiological interplay between the heart and kidneys, where acute or chronic dysfunction in one organ induces dysfunction in the…
Krabbe Disease Market Set for Advancements by 2034: Newborn Screening, Research, …
Krabbe disease is a rare, inherited lysosomal storage disorder caused by mutations in the GALC gene, leading to the progressive loss of myelin in the…
Rheumatic Heart Disease Market Projected for Steady Growth through 2034: Advance …
Rheumatic Heart Disease (RHD) is a chronic, potentially debilitating condition caused by damage to heart valves following untreated or poorly managed rheumatic fever, itself triggered…
Rosai-Dorfman Disease Market Forecast to Experience Steady Growth Through 2034: …
Rosai-Dorfman Disease (RDD) is a rare and complex histiocytic disorder marked by the abnormal accumulation of histiocytes, leading to diverse clinical presentations that challenge diagnosis…
Acute-on-Chronic Liver Failure Market Set for Meaningful Growth by 2034: Advanci …
Acute-on-Chronic Liver Failure (ACLF) is a life-threatening condition characterized by acute hepatic decompensation in patients with pre-existing chronic liver disease, often accompanied by multi-organ failure…
Metrorrhagia Market Set for Steady Growth through 2034: Emerging Therapies and E …
Metrorrhagia, characterized by abnormal uterine bleeding between menstrual periods, affects a significant portion of women globally, impacting quality of life and leading to various healthcare…
Essential Thrombocythemia Market Set for Steady Growth by 2034: Emerging Therapi …
Essential Thrombocythemia (ET), a rare chronic myeloproliferative neoplasm characterized by an abnormally high platelet count, poses considerable clinical challenges due to risks of thrombosis, hemorrhage,…
Palmar Fibromatosis Market Set to Transform by 2034 Fueled by Advancements in Tr …
Palmar Fibromatosis, also known as Dupuytren's contracture, is a progressive fibrotic disorder characterized by the thickening and contracture of the palmar fascia, leading to impaired…
Chronic Fatigue Syndrome (CFS) Market Expected to Evolve by 2034 Driven by Incre …
Chronic Fatigue Syndrome (CFS), also known as Myalgic Encephalomyelitis (ME), is a complex, debilitating disorder characterized by profound fatigue, cognitive dysfunction, and a range of…
Antibody-mediated Rejection (AMR) Market Expected to Grow Significantly by 2034 …
Antibody-mediated rejection (AMR), a major cause of graft dysfunction and failure following solid organ transplantation, represents a persistent challenge in the field of transplant immunology.…
Antiphospholipid Syndrome Market Outlook 2034: Diagnostic Advancements and Pipel …
Antiphospholipid Syndrome (APS), a chronic autoimmune disorder marked by recurrent arterial or venous thrombosis and pregnancy-related complications, remains a complex and under-recognized clinical challenge. Characterized…
Aarskog-Scott Syndrome Market Outlook 2034: Advancing Genetic Understanding and …
Aarskog-Scott Syndrome (AAS), also known as faciogenital dysplasia, is a rare X-linked genetic disorder caused by mutations in the FGD1 gene. It is primarily characterized…
Chronic Pain - Market Insights, Epidemiology, and Forecast 2034: Embracing Multi …
Chronic pain, defined as persistent or recurrent pain lasting longer than three months, is a widespread and debilitating condition impacting physical, emotional, and social well-being.…
Narcolepsy Market Insight, Epidemiology, and Market Forecast - 2034: Innovation …
Narcolepsy, a chronic neurological disorder affecting the brain's ability to regulate sleep-wake cycles, significantly impairs patients' daily functioning and quality of life. Characterized by excessive…
Danon Disease Market Outlook 2034: Gene Therapies and Precision Medicine Drive F …
Danon Disease, an ultra-rare, X-linked dominant genetic disorder caused by mutations in the LAMP2 gene, leads to impaired autophagy and lysosomal dysfunction, predominantly affecting the…
Wolman Disease Market Forecast 2034: Advancing Therapeutics in an Ultra-Rare Lan …
Wolman Disease, a severe and ultra-rare lysosomal storage disorder caused by mutations in the LIPA gene, leads to a near-complete deficiency of lysosomal acid lipase…
AL Amyloidosis Market Outlook 2034: Rising Awareness and Emerging Therapies Set …
AL (Light Chain) Amyloidosis, a rare and life-threatening disorder characterized by the abnormal deposition of misfolded light chain proteins in vital organs, continues to pose…
Mantle Cell Lymphoma Treatment Market Size in 7MM is expected to grow at a decen …
DelveInsight's "Mantle Cell Lymphoma Treatment Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Mantle cell lymphoma, historical and…
T-Cell Prolymphocytic Leukemia Pipeline: 5+ Companies Advancing Novel Therapeuti …
The therapeutic landscape for T-Cell Prolymphocytic Leukemia (T-PLL), a rare and aggressive form of mature T-cell leukemia, is witnessing growing research interest as biotech and…
Propionic Acidemia Pipeline Insights 2025: Emerging Therapies and Future Treatme …
The therapeutic landscape for Propionic Acidemia (PA), a rare inherited metabolic disorder caused by deficiency of the propionyl-CoA carboxylase enzyme, is advancing steadily with multiple…
Primary Mitochondrial Myopathies (PMM) Pipeline: Advancing Therapies Targeting M …
The therapeutic landscape for Primary Mitochondrial Myopathies (PMM) is rapidly progressing, driven by the urgent need to address the complex and heterogeneous nature of these…
Minimal Change Disease Pipeline: Advancing Targeted Therapies for Improved Patie …
The therapeutic landscape for Minimal Change Disease (MCD) is witnessing promising advancements as researchers and biopharmaceutical companies focus on developing innovative treatments to address this…
Nosocomial Pneumonia Pipeline: Key Advances and Emerging Therapies Shaping Treat …
The treatment landscape for Nosocomial Pneumonia continues to advance, driven by the urgent need to combat antibiotic resistance and improve patient outcomes in hospital settings.…
Cardiogenic Shock Pipeline: Advancing Therapeutics and Innovative Interventions …
Cardiogenic Shock (CS), a life-threatening condition marked by the heart's inability to pump sufficient blood to meet the body's needs, remains a critical unmet need…
Central Serous Chorioretinopathy Pipeline: Emerging Therapies and Future Outlook …
Central Serous Chorioretinopathy (CSCR) is a retinal disorder with limited treatment options and significant unmet needs. The CSCR pipeline is evolving with innovative therapies targeting…
Centronuclear Myopathy Pipeline: 5+ Companies Advancing Therapies for Rare Neuro …
The treatment landscape for Centronuclear Myopathy (CNM), a group of rare inherited neuromuscular disorders characterized by muscle weakness and abnormal centralization of nuclei in muscle…
Chronic Hepatitis C Virus Infection Pipeline: 8+ Companies Advancing Therapies f …
The therapeutic landscape for Chronic Hepatitis C Virus (HCV) infection continues to evolve, with a focus on advancing antiviral regimens and enhancing treatment outcomes. Despite…
Chronic Hepatitis B Virus Pipeline: 50+ Companies Driving Next-Generation Therap …
The therapeutic landscape for Chronic Hepatitis B Virus (HBV) infection, a globally prevalent and potentially life-threatening liver disease, is rapidly evolving with innovative treatment candidates…
Laband Syndrome Market Outlook Poised for Scientific Attention by 2034 | DelveIn …
Laband Syndrome, also known as Zimmermann-Laband Syndrome, is an ultra-rare genetic disorder marked by gingival fibromatosis, distinctive facial features, joint hypermobility, and nail and bone…
Palmar Hyperhidrosis Market Set for Strong Growth by 2034 - DelveInsight | Key P …
Palmar Hyperhidrosis, a chronic dermatological condition characterized by excessive sweating of the palms, continues to impact quality of life and psychological well-being for millions of…
Vaso-Occlusive Crisis Market Set for Significant Growth by 2034 - DelveInsight | …
Vaso-Occlusive Crisis (VOC), a severe and painful complication of sickle cell disease, poses a substantial burden on patients and healthcare systems globally. The VOC market…
Leigh Syndrome Market Poised for Robust Growth by 2034: Unlocking New Therapies …
Leigh Syndrome, a rare and severe mitochondrial disorder predominantly affecting infants and young children, presents significant clinical challenges due to its complex neurological manifestations and…
Thymidine Kinase 2 Deficiency Market Set to Witness Significant Growth by 2034 | …
Thymidine Kinase 2 (TK2) Deficiency, a rare and progressive mitochondrial DNA depletion syndrome, presents considerable challenges in diagnosis, clinical management, and long-term outcomes due to…
BRAF-mutant Non-Small Cell Lung Cancer Pipeline: 10+ Companies Advancing Targete …
The treatment landscape for BRAF-mutant Non-Small Cell Lung Cancer (BRAF+ NSCLC), a molecular subtype of NSCLC driven by mutations in the BRAF gene, most commonly…
ALK-positive Non-Small Cell Lung Cancer Pipeline: Companies Advancing Targeted T …
The therapeutic landscape for ALK-positive Non-Small Cell Lung Cancer (ALK+ NSCLC), a genetically defined subset of lung cancer driven by ALK gene rearrangements, is undergoing…
Bruton's Tyrosine Kinase (BTK) Inhibitors Pipeline Set to Transform Oncology and …
The therapeutic landscape for Bruton's Tyrosine Kinase (BTK) inhibitors is undergoing a significant transformation, driven by the urgent need for targeted therapies in oncology and…
Fabry Disease Pipeline Overview: Over 18 Companies Driving Innovation in Targete …
The therapeutic landscape for Fabry disease, a rare genetic lysosomal storage disorder caused by deficient alpha-galactosidase A enzyme activity, is undergoing significant transformation. Biopharmaceutical developers…
